354 related articles for article (PubMed ID: 19268406)
21. Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
Kowalczyk P; Sałat K; Höfner GC; Mucha M; Rapacz A; Podkowa A; Filipek B; Wanner KT; Kulig K
Eur J Med Chem; 2014 Aug; 83():256-73. PubMed ID: 24973660
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione.
Obniska J; Kołaczkowski M; Bojarski AJ; Duszyńska B
Eur J Med Chem; 2006 Jul; 41(7):874-81. PubMed ID: 16600439
[TBL] [Abstract][Full Text] [Related]
24. Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones.
Yogeeswari P; Sriram D; Mehta S; Nigam D; Kumar MM; Murugesan S; Stables JP
Farmaco; 2005 Jan; 60(1):1-5. PubMed ID: 15652361
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anticonvulsant activity of 6-alkoxy-[1,2,4]triazolo[3,4-a]phthalazines.
Zhang L; Guan LP; Sun XY; Wei CX; Chai KY; Quan ZS
Chem Biol Drug Des; 2009 Mar; 73(3):313-9. PubMed ID: 19207467
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of some newer derivatives of substituted quinazolinonyl-2-oxo/thiobarbituric acid as potent anticonvulsant agents.
Archana ; Srivastava VK; Kumar A
Bioorg Med Chem; 2004 Mar; 12(5):1257-64. PubMed ID: 14980637
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization and antifungal activities of some benzenesulphonylamino acid derivatives.
Abdel-Ghaffar SA; Mpango GB; Ismail MA; Nanyonga SK
Boll Chim Farm; 2002; 141(5):389-93. PubMed ID: 12481383
[TBL] [Abstract][Full Text] [Related]
28. Central activity of new xanthone derivatives with chiral center in some pharmacological tests in mice.
Jastrzebska-Wiesek M; Librowski T; Czarnecki R; Marona H; Nowak G
Pol J Pharmacol; 2003; 55(3):461-5. PubMed ID: 14506327
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and potential biological activity of some novel 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles and 3,6-diamino-4-(N-substituted indol-3-yl)pyrano(2,3-c)pyrazole-5-carbonitriles.
Mandour AH; El-Sawy ER; Ebaid MS; Hassan SM
Acta Pharm; 2012 Mar; 62(1):15-30. PubMed ID: 22472446
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of 2,6-piperidinedione derivatives as potentially novel compounds with analgesic and other CNS activities.
El Batran SA; Osman AE; Ismail MM; El Sayed AM
Inflammopharmacology; 2006 Mar; 14(1-2):62-71. PubMed ID: 16835715
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of some new substituted triazolo [4,3-a][1,4] benzodiazepine derivatives as potent anticonvulsants.
Narayana B; Vijaya Raj KK; Ashalatha BV; Kumari NS
Eur J Med Chem; 2006 Mar; 41(3):417-22. PubMed ID: 16472891
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives.
Ghidini E; Delcanale M; De Fanti R; Rizzi A; Mazzuferi M; Rodi D; Simonato M; Lipreri M; Bassani F; Battipaglia L; Bergamaschi M; Villetti G
Bioorg Med Chem; 2006 May; 14(10):3263-74. PubMed ID: 16460950
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anticonvulsant activity of new N-(alkyl/sub-stituted aryl)-N'-[4-(5-cyclohexylamino)-1,3,4-thiadiazole-2-yl)phenyl]thioureas.
Karakus S; Koçyiğit-Kaymakcioğlu B; Toklu HZ; Aricioglu F; Rollas S
Arch Pharm (Weinheim); 2009 Jan; 342(1):48-53. PubMed ID: 19035387
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and anticonvulsant evaluation of some new 2-substituted-3-arylpyrido[2,3-d]pyrimidinones.
White DC; Greenwood TD; Downey AL; Bloomquist JR; Wolfe JF
Bioorg Med Chem; 2004 Nov; 12(21):5711-7. PubMed ID: 15465347
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2''-hydroxy naphthalen-1''-yl)-1,5-diphenyl-2-pyrazolines.
Rajendra Prasad Y; Lakshmana Rao A; Prasoona L; Murali K; Ravi Kumar P
Bioorg Med Chem Lett; 2005 Nov; 15(22):5030-4. PubMed ID: 16168645
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 2-substituted-6-(4H-1,2,4-triazol-4-yl)benzo[d]oxazoles as potential anticonvulsant agents.
Wei CX; Guan LP; Jia JH; Chai KY; Quan ZS
Arch Pharm Res; 2009 Jan; 32(1):23-31. PubMed ID: 19183873
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of 5-alkoxy-[1,2,4]triazolo[4,3-a]quinoline derivatives with anticonvulsant activity.
Guo LJ; Wei CX; Jia JH; Zhao LM; Quan ZS
Eur J Med Chem; 2009 Mar; 44(3):954-8. PubMed ID: 18752871
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of ring-opened derivatives of triazole-containing quinolinones and their antidepressant and anticonvulsant activities.
Song MX; Huang YS; Zhou QG; Deng XQ; Yao XD
Bioorg Chem; 2021 Jan; 106():104505. PubMed ID: 33279249
[TBL] [Abstract][Full Text] [Related]
40. Effects of some 1,3,5-trisubstitued-2-pyrazoline derivatives on depression and anxiety parameters of mice.
Can OD; Ozkay UD; Kaplancikli ZA; Oztürk Y
Arch Pharm Res; 2009 Sep; 32(9):1293-9. PubMed ID: 19784586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
